Pharmaceutical - ShangPharma


Current filters:


Popular Filters

ShangPharma milestone in Hengrui accord; expands Lilly contract


Leading Chinese R&D outsourcing firm ShangPharma Corp (NYSE: SHP) says that it has reached the first…

Asia-PacificEli LillyJiangsu Hengrui MedicinePharmaceuticalResearchShangPharma

Management changes at Mylan, Transition Thera, Pfizer and ShangPharma


US generic drug major Mylan (Nasdaq: MYL) has announced the appointment of John Thievon as president…

GenericsManagementMylan LaboratoriesPharmaceuticalShangPharmaTransition Therapeutics

WuXi PharmaTech acquires China-based clinical services companies; ShangPharma buys Charles River research facility


WuXi PharmaTech (NYSE: WX) says it has acquired MedKey Med-Tech Development and Jiecheng Med-Tech Development,…

BiotechnologyCharles River LaboratoriesMergers & AcquisitionsPharmaceuticalShangPharmaWuXi Apptec

Back to top